Axonal Damage in Multiple Sclerosis: Strategies for Protection and Repair (R21)
The summary for the Axonal Damage in Multiple Sclerosis: Strategies for Protection and Repair (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Axonal Damage in Multiple Sclerosis: Strategies for Protection and Repair (R21): This funding opportunity announcement (FOA) with set-aside funds invites applications proposing clinical and translational research in multiple sclerosis (MS) that target the neurodegenerative aspect of this disease. Applicants are expected to propose activities that are directly focused on the development of neuroprotective and regenerative therapies for MS. Applications in basic neuroscience or glial biology are not covered under this FOA. Applications for clinical trials and interventional studies are directed to use the funding mechanisms and opportunities listed at http://www.ninds.nih.gov/funding/areas/clinical_trials/index.htm. -This funding opportunity will use the NIH Exploratory/Developmental Grant (R21) award mechanism but will run in parallel with an FOA of identical scientific scope that utilizes the traditional research project grant (R01) (PAS-05-002) mechanism. -The total amount to be awarded is up to $1,500,000 for the duration of this solicitation (3 years), in addition to funds available for applications sent in response to this funding opportunity announcement and a parallel announcement that uses the R01 mechanism that score within the NINDS payline. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -Eligible organizations: For-profit or non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State and local governments; eligible agencies of the Federal government; domestic or foreign institutions/organizations; units of state or local tribal governments; and faith-based or community-based organizations. -Eligible Project Directors/Principal Investigators (PD/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -An R21 is not renewable. -Applicants may submit more than one application, provided each is scientifically distinct.
|Federal Grant Title:||Axonal Damage in Multiple Sclerosis: Strategies for Protection and Repair (R21)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PAS-06-266|
|Type of Funding:||Grant|
|CFDA Descriptions:||Extramural Research Programs in the Neurosciences and Neurological Disorders|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple Receipt Dates - See Link to Full Announce|
|Posted Date:||Mar 24, 2006|
|Creation Date:||Sep 18, 2007|
|Archive Date:||Feb 07, 2008|
|Total Program Funding:||$1,500,000|
|Maximum Federal Grant Award:||$200,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Special district governments Public and State controlled institutions of higher education For profit organizations other than small businesses State governments County governments City or township governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Private institutions of higher education
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Similar Government Grants
- • NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdocto...
- • Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed)
- • Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial...
- • The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed)
- • Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disord...
- • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
- • NINDS Institutional Center Core Grants to Support Neuroscience Research
- • Career Development Award to Promote Diversity in Neuroscience Research
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...